Çocukluk Çağı Lökodistrofileri ve Görüntüleme Bulguları

Gujral J, Sethuram S. An update on the diagnosis and treatment of adrenoleukodystrophy. Curr Opin Endocrinol Diabetes Obes. 2023 Feb 1;30(1):44-51. doi: 10.1097/MED.0000000000000782. Epub 2022 Nov 14. PMID: 36373727.

Nave KA, Werner HB (2014) Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol 30:503–533. doi:10.1146/annurev-cellbio-100913-013101

Engelen M, Kemp S, de Visser M, et al X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012 Aug 13; 7:51. doi: 10.1186/1750-1172-7-51. PMID: 22889154; PMCID: PMC3503704.

Migeon, B.R.; Moser, H.W.; Moser, A.B.; Axelman, J.; Sillence, D.; Norum, R.A. Adrenoleukodystrophy: Evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. Proc. Natl. Acad. Sci. USA 1981, 78, 5066–5070. [CrossRef]

van der Knaap, M.S.; Bugiani, M. Leukodystrophies: A proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathol. 2017, 134, 351–382. [CrossRef] [PubMed]

Sarret C. Leukodystrophies and genetic leukoencephalopathies in children. Rev Neurol (Paris). 2020 Jan-Feb;176(1-2):10-19. doi: 10.1016/j.neurol.2019.04.003. Epub 2019 Jun 4. PMID: 31174885.

Singh I, Singh AK, Contreras MA. Peroxisomal dysfunction in inflammatory childhood white matter disorders: an unexpected contributor to neuropathology. J Child Neurol. 2009 Sep;24(9):1147-57. doi: 10.1177/0883073809338327. Epub 2009 Jul 15. PMID: 19605772; PMCID: PMC3077730.

Wanders, RJ.; Barth, PG.; Heymans, HS. Single peroxisomal enzyme deficiencies. In: Scriver, CR.; Beaudet, AL.; Sly, WS.; Valle, D., editors. The Metabolic & Molecular Bases of Inherited Disease. McGraw-Hill; New York: 2001. p. 3219-3256.

McGuinnes MC, Lu JF, Zhang HP, et al. Role of ALDP(ABCD1) and mithocondria in X-linked adrenoleucodystrophy. Mol Cell Biol 2003; 23: 744-753.

Contreras M, Singh I. Adrenoleukodystrophy: Molecular, Metabolic, Pathologic, and Therapeutic Aspects. In: Lajtha A, editor. Handbook of Neurochemistry and Molecular Neurobiology. Springer; New York: 2009. pp. 13–42.

Loes DJ, Fatemi A, Melhem ER et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003;61(3):369-374.

Melhem ER, Loes DJ, Georgiades CS, Raymond GV, Moser HW. X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. AJNR Am J Neuroradiol 2000;21(5):839–844.

Bizzi A, Castelli G, Bugiani M et-al. Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol 2008;29(7):1270-1275.

Eichler F, Duncan C, Musolino PL, et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med. 2017;377(17):1630–1638.

Fumagalli F, Calbi V, Natali Sora MG et al. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access. Lancet. 2022 Jan 22;399(10322):372-383. doi: 10.1016/S0140-6736(21)02017-1. PMID: 35065785; PMCID: PMC8795071.

Kim TS, Kim IO, Kim WS et al. MR of childhood metachromatic leukodystrophy. AJNR Am J Neuroradiol 1997;18(4):733-738.

Resende LL, de Paiva ARB, Kok F, da Costa Leite C, Lucato LT. Adult leukodystrophies: A step-by-step diagnostic approach. Radiographics 2019;39(1):153-168.

Koh SY, Choi YH, Lee SB, Lee S, Cho YJ, Cheon JE. Comparing initial magnetic resonance imaging findings to differentiate between Krabbe disease and metachromatic leukodystrophy in children. Investig Magn Reson Imaging 2021;25(2):101-108.

Maghazachi A. A. (2023). Globoid Cell Leukodystrophy (Krabbe Disease): An Update. ImmunoTargets and therapy, 12, 105–111. https://doi.org/10.2147/ITT.S424622

Orsini, J. J., Escolar, M. L., Wasserstein, M. P., & Caggana, M. (2000). Krabbe Disease. In M. P. Adam (Eds.) et. al., GeneReviews®. University of Washington, Seattle.

Given CA 2nd, Santos CC, Durden DD. Intracranial and spinal MR imaging findings associated with Krabbe's disease: case report. AJNR Am J Neuroradiol 2001;22(9):1782-5.

Choi S, Enzmann DR. Infantile Krabbe disease: complementary CT and MR findings. AJNR Am J Neuroradiol 1993;14(5):1164-6.

Cheon JE, Kim IO, Hwang YS, et al. Leukodystrophy in children: a pictorial review of MR imaging features. Radiographics 2002;22(3):461-476.

Kwon, J. M., Matern, D., Kurtzberg, J., et al (2018). Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease. Orphanet journal of rare diseases, 13(1), 30. https://doi.org/10.1186/s13023-018-0766-x

Wright MD, Poe MD, DeRenzo A, Haldal S, Escolar ML. Developmental outcomes of cord blood transplantation for Krabbe disease: a 15-year study. Neurology. 2017;89:1365–72.

Nagy, A., Bley, A. E., & Eichler, F. (1999). Canavan Disease. In M. P. Adam (Eds.) et.al., GeneReviews®. University of Washington, Seattle.

Sreenivasan P, Purushothaman KK. Radiological clue to diagnosis of Canavan disease. Indian J Pediatr. 2013;80(1):75-77.

Brismar J, Brismar G, Gascon G, Ozand P. Canavan disease: CT and MR imaging of the brain. AJNR Am J Neuroradiol. 1990;11(4):805-810.

Reddy N, Calloni SF, Vernon HJ, Boltshauser E, Huisman TAGM, Soares BP. Neuroimaging findings of organic acidemias and aminoacidopathies. Radiographics 2018;38(3):912-931.

Rossler, L., Lemburg, S., Weitkämper, A., et al. (2023). Canavan's spongiform leukodystrophy (Aspartoacylase deficiency) with emphasis on sonographic features in infancy: description of a case report and review of the literature. Journal of ultrasound, 26(4), 757–764. https://doi.org/10.1007/s40477-022-00667-2

Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS. Leukoencephalopathy with vanishing white matter: a review. J Neuropathol Exp Neurol 2010; 69(10): 987-6.

Ashrafi, M. R., Amanat, M., Garshasbi et al (2020). An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies. Expert review of neurotherapeutics, 20(1), 65–84. https://doi.org/10.1080/14737175.2020.1699060

Van der Knaap MS, Leegwater PA, Könst AA, et al. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol. 2002 Feb;51(2):264-70. doi: 10.1002/ana.10112. PMID: 11835386.

van der Knaap MS, Abbink TEM. Ovarioleukodystrophy: Vanishing white matter versus AARS2-related ovarioleukodystrophy. Clin Neurol Neurosurg. 2018 Aug;171:195. doi: 10.1016/j.clineuro.2018.06.024. Epub 2018 Jun 22. PMID: 29954622.

Senol U, Haspolat S, Karaali K, Lüleci E. MR imaging of vanishing white matter. AJR Am J Roentgenol. 2000 Sep;175(3):826-8. doi: 10.2214/ajr.175.3.1750826. PMID: 10954652.

van der Knaap MS, Barth PG, Gabreëls FJ, et al. A new leukoencephalopathy with vanishing white matter. Neurology. 1997 Apr;48(4):845-55. doi: 10.1212/wnl.48.4.845. PMID: 9109866.

Yoshida T, Sasaki M, Yoshida M, et al; Alexander Disease Study Group in Japan. Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. J Neurol. 2011 Nov;258(11):1998-2008. doi: 10.1007/s00415-011-6056-3. Epub 2011 May 1. PMID: 21533827.

Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res. 2000 Oct;25(9-10):1439-51. doi: 10.1023/a:1007677003387. PMID: 11059815.

Springer S, Erlewein R, Naegele T, et al. Alexander disease--classification revisited and isolation of a neonatal form. Neuropediatrics. 2000 Apr;31(2):86-92. doi: 10.1055/s-2000-7479. PMID: 10832583.

Nishibayashi F, Kawashima M, Katada Y, Murakami N, Nozaki M. Infantile-onset Alexander disease in a child with long-term follow-up by serial magnetic resonance imaging: a case report. J Med Case Rep. 2013 Jul 26;7:194. doi: 10.1186/1752-1947-7-194. PMID: 23890466; PMCID: PMC4231460.

Miller, J. C., and N. U. Raul. "Magnetic resonance spectroscopy in the brain." Massachusetts General Hospital Depatment of Radiology 10 (2012): 1-6.

Hoffman-Zacharska D, Mierzewska H, Szczepanik E, et al; (2013) The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease. Med Wieku Rozwoj 17:293–300

Osório MJ, Goldman SA. Neurogenetics of Pelizaeus-Merzbacher disease. Handb Clin Neurol. 2018; 148:701-722.

Singh R, Samanta D. Pelizaeus-Merzbacher Disease. [Updated 2023 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-

Pizzini F, Fatemi AS, Barker PB, et al. Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease. AJNR Am J Neuroradiol. 2003 Sep;24(8):1683-9.